BCYC
Price
$24.59
Change
-$1.13 (-4.39%)
Updated
Mar 4, 12:22 PM EST
59 days until earnings call
BMEA
Price
$17.20
Change
-$0.61 (-3.43%)
Updated
Mar 4, 12:34 PM EST
Earnings call today
Ad is loading...

Compare trend and price BCYC vs BMEA

Header iconBCYC vs BMEA Comparison
Open Charts BCYC vs BMEABanner chart's image
Bicycle Therapeutics
Price$24.59
Change-$1.13 (-4.39%)
Volume$500
CapitalizationN/A
Biomea Fusion
Price$17.20
Change-$0.61 (-3.43%)
Volume$729
CapitalizationN/A
View a ticker or compare two or three
BCYC vs BMEA Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BMEADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. BMEA commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and BMEA is a Hold.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (BCYC: $25.72 vs. BMEA: $17.81)
Brand notoriety: BCYC and BMEA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 109% vs. BMEA: 84%
Market capitalization -- BCYC: $974.28M vs. BMEA: $635.92M
BCYC [@Biotechnology] is valued at $974.28M. BMEA’s [@Biotechnology] market capitalization is $635.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileBMEA’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • BMEA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCYC and BMEA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while BMEA’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • BMEA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than BMEA.

Price Growth

BCYC (@Biotechnology) experienced а +4.38% price change this week, while BMEA (@Biotechnology) price change was +11.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.35%. For the same industry, the average monthly price growth was +19.12%, and the average quarterly price growth was +52.87%.

Reported Earning Dates

BCYC is expected to report earnings on May 02, 2024.

BMEA is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (+4.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for BMEA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCYC($974M) has a higher market cap than BMEA($636M). BCYC YTD gains are higher at: 42.257 vs. BMEA (22.658). BMEA has higher annual earnings (EBITDA): -113.81M vs. BCYC (-169.4M). BCYC has more cash in the bank: 526M vs. BMEA (199M). BMEA has less debt than BCYC: BMEA (12.1M) vs BCYC (45M). BCYC has higher revenues than BMEA: BCYC (27M) vs BMEA (0).
BCYCBMEABCYC / BMEA
Capitalization974M636M153%
EBITDA-169.4M-113.81M149%
Gain YTD42.25722.658186%
P/E RatioN/AN/A-
Revenue27M0-
Total Cash526M199M264%
Total Debt45M12.1M372%
TECHNICAL ANALYSIS
Technical Analysis
BCYCBMEA
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BMEADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TFCGX18.170.35
+1.96%
Taylor Frigon Core Growth
JTKCX13.510.17
+1.27%
JHancock Global Thematic Opps C
MLPFX7.690.07
+0.92%
Invesco SteelPath MLP Select 40 A
MDISX31.220.15
+0.48%
Franklin Mutual Global Discovery Z
ARMIX9.690.04
+0.41%
ARGA Emerging Markets Value Instl

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+2.51%
PHIO - BCYC
41%
Loosely correlated
-11.28%
MLTX - BCYC
39%
Loosely correlated
+5.56%
ABUS - BCYC
37%
Loosely correlated
-0.36%
ORMP - BCYC
35%
Loosely correlated
+3.95%
SAGE - BCYC
34%
Loosely correlated
+1.77%
More

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with VKTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+1.77%
VKTX - BMEA
49%
Loosely correlated
+10.60%
TERN - BMEA
38%
Loosely correlated
-0.14%
INZY - BMEA
38%
Loosely correlated
+2.99%
COGT - BMEA
35%
Loosely correlated
+3.29%
WVE - BMEA
33%
Loosely correlated
+6.65%
More